Welcome to our dedicated page for MEDMEN ENTPRS B SUB VTG news (Ticker: MMNFF), a resource for investors and traders seeking the latest updates and insights on MEDMEN ENTPRS B SUB VTG stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect MEDMEN ENTPRS B SUB VTG's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of MEDMEN ENTPRS B SUB VTG's position in the market.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
MedMen Enterprises announced a change in its auditor from MNP LLP to Marcum LLP, effective March 17, 2023. The previous auditor's report did not contain adverse opinions, but highlighted the company’s ongoing concerns regarding its ability to continue as a going concern due to recurring losses, debt covenant violations, and net capital deficiency. These concerns were attributed to a material weakness in financial record-keeping and ineffective controls over reconciliation processes. The Audit Committee approved Marcum LLP as the new independent registered public accountant for the fiscal year ending July 1, 2023.